Response to Blier letter

American Journal of Psychiatry

Volumn 169, Issue 1, 2012, Pages 95-96

  Trivedi, Madhukar H ^a   Rush, A John ^a   Kurian, Ben T ^a   Nierenberg, Andrew A ^a   Wisniewski, Stephen R ^a   Fava, Maurizio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; VENLAFAXINE;

DEPRESSION; DRUG DOSE INCREASE; DRUG RESPONSE; HUMAN; LETTER; MAJOR DEPRESSION; MELANCHOLIA; MONOTHERAPY; PRIORITY JOURNAL; REMISSION; UNSPECIFIED SIDE EFFECT;

EID: 84857578463     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11071055r     Document Type: Letter

References (4)

1. Blier P, Ward HE, Tremblay P, Laberge L, Hebert C, Bergeron R: Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 2010; 167:281-288
2. Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR: Combining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011; 168:689-701
3. Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF: Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol 2002; 22:379-387 (Pubitemid 34810327)
4. Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM: Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 1994; 151:1372-1374 (Pubitemid 24281764)